Full Press Release Details
| Investor News | Fresenius Medical Care AG & Co. KGaA | |
| Investor Relations | ||
| Else-Kr ner-Str. 1 | ||
| D-61352 Bad Homburg | ||
| Contact: | ||
| Oliver Maier | ||
| Phone: | + 49 6172 609 2601 | |
| Fax: | + 49 6172 609 2301 | |
| E-mail: | ir@fmc-ag.com | |
| North America: | ||
| Terry L. Morris | ||
| Phone: | + 1 800 948 2538 | |
| Fax: | + 1 615 345 5605 | |
| E-mail: | ir@fmc-ag.com | |
| Internet: www.fmc-ag.com | ||
| For immediate release | ||
| February 25, 2010 |
Medical Care Publishes Form 20-F
for the Fiscal Year 2009
Germany Fresenius Medical Care AG
& Co. KGaA ( the Company or FMC AG & Co. KGaA ), the world s largest
provider of dialysis products and services, today announced that it has filed the annual
report 2009 under Form 20-F with the U.S. Securities and Exchange Commission
The report is available at the Company s website
in the Investor Relations section:http://www.fmc-ag.com/2032.htm, as well as at the SEC s website,
A hard copy of Fresenius Medical Care s annual report
on Form 20-F including the complete audited financial statements may be
obtained from the Company free of charge upon request to the Company s Investor
Relations department by email at
Medical Care is the world s largest integrated provider of products and
services for individuals undergoing dialysis because of chronic kidney failure,
a condition that affects more than 1,890,000 individuals worldwide. Through its
network of 2,553 dialysis clinics in North America, Europe, Latin America,
Asia-Pacific and Africa, Fresenius Medical Care provides dialysis treatment to 195,651
patients around the globe. Fresenius Medical Care is also the world s leading
provider of dialysis products such as hemodialysis machines, dialyzers and
related disposable products. Fresenius Medical Care is listed on the Frankfurt
Stock Exchange (FME, FME3) and the New York Stock Exchange (FMS, FMS/P).
more information about Fresenius Medical Care visit the Company s website at www.fmc-ag.com.
release contains forward-looking statements that are subject to various risks
and uncertainties. Actual results could differ materially from those described
in these forward-looking statements due to certain factors, including changes
in business, economic and competitive conditions, regulatory reforms, foreign
exchange rate fluctuations, uncertainties in litigation or investigative
proceedings, and the availability of financing. These and other risks and
uncertainties are detailed in Fresenius Medical Care AG & Co. KGaA s
reports filed with the U.S. Securities and Exchange Commission. Fresenius
Medical Care AG & Co. KGaA does not undertake any responsibility to update the forward-looking
statements in this release.